Reflecting on the turbulent first nine months of 2026, Jim Cramer and the Motley Fool’s Investment Club have identified critical lessons from twelve significant stock exits. The year has been marked by geopolitical shocks, including the U.S.-Iran conflict that drove oil prices skyward and sent the S&P 500 into a tailspin, followed by a powerful nine-week rally that pushed the index to an all-time high in mid-August. Amid this volatility, the Club executed 141 trades, with 75 sales highlighting both disciplined successes and humbling errors.
Leading the list of regrets is the sale of Honeywell Aerospace, which Cramer described as the single biggest disappointment of his 46-year career. Following the spin-off in late June, the standalone company issued a drastically lowered guidance forecast in early August due to supply chain constraints. The stock plummeted 23% the next day, forcing the Club to sell at approximately a 15% loss. Cramer attributed the error to management misrepresentation rather than investor mistake, recalling actor Gene Hackman’s advice: “Sometimes, you just get had.”
The portfolio also suffered from excessive patience regarding turnaround candidates Nike and Danaher. The Nike exit resulted in a steep 40% loss after the club ignored weak stock performance in favor of insider buying signals from CEO Elliott Hill and board member Tim Cook. Cramer admitted that he allowed his discipline to lapse, underestimating the depth of Nike’s structural problems. Similarly, Danaher saw a 7% loss in February because the anticipated normalization of its bioprocessing business failed to materialize, prompting regrets that the position should have been sold near its 52-week highs just a month prior.
Not all exits were driven by distress. The Club sold Solstice Advanced Materials in January after a strong run, booking a 13% gain while the company’s fundamentals remained sound for data center and nuclear energy markets. In March, BlackRock was sold to raise cash ahead of Middle Eastern tensions, yielding a 7% profit as capital was rotated into defensive healthcare name Cardinal Health. Additionally, Bristol Myers Squibb was swapped for Johnson & Johnson in April to secure a 3.5% gain, favoring J&J’s stronger long-term outlook and FDA-approved Icotyde over Bristol’s pending patent cliff.
Premature exits from Texas Roadhouse and Cisco Systems represent another area for improvement. The Club sold Texas Roadhouse in February after a triple earnings miss, locking in a 12% profit despite the stock later rallying another 8%. Cisco was sold a month later during a market pullback at $80.48, missing out on subsequent gains that brought the price to roughly $111, though the club still realized an 18% profit on earlier shares. Finally, timely exits from Procter & Gamble and Dover following earnings disappointments allowed the Club to reallocate capital into high-conviction ideas like Micron, which has since contributed positively to performance.
Leave a Reply